At the Fred Hutchinson Cancer Center (Fred Hutch), we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We are committed to increasing our awareness and improving our practices so that we are an organization known as a center of diversity and inclusion excellence. As a part of this effort, we are committed to advancing diversity, equity, and inclusion in scientific research and supporting the career development of the next generation of scientists.
Overview:
Fred Hutch is seeking applications for the 5th Annual Dr. Eddie Méndez Scholar Award, which recognizes outstanding postdoctoral fellows from any discipline conducting research on cancer, infectious diseases, or basic science. The award was created to recognize Dr. Méndez’s commitment to cancer research and supporting early-career scientists from historically excluded backgrounds. This award aims to build a community between postdoctoral scholars aiming to pursue academic faculty careers and scientists at Fred Hutch.
This award recognizes the achievements of post-doctoral fellows from backgrounds that are underrepresented in science based on the NIH definition, which includes individuals from underrepresented racial and ethnic groups (Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders), individuals with disabilities, and individuals from disadvantaged backgrounds. We acknowledge that not all groups historically excluded from science are within the NIH definition and have expanded eligibility to also include scientists who are LGBTQ+, formerly incarcerated, and more. A selection committee consisting of Fred Hutch faculty will select up to ten awardees. Fred Hutch will provide an honorarium to awardees, and Fred Hutch will cover all expenses related to travel and accommodations.
Awardees will present at a scientific symposium honoring Dr. Eddie Méndez and have the opportunity to meet with Fred Hutch faculty and senior leaders. We plan this event in person on the Fred Hutch campus in Seattle sometime between September-October 2023.
The aims of this award are to:
Dr. Méndez, who died of cancer in 2018, specialized in treating head-and-neck cancer, an often disfiguring and debilitating disease. It was his mission to save lives and improve the well-being of cancer patients, whether through spearheading minimally invasive robotic surgery for these tumors (he was the first in Washington state to perform such surgery) or tirelessly developing new treatments in his laboratory at Fred Hutch.
Your search for "" did not match any of our available careers. Please try another search term or combination of terms and filters.